ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
9,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
9,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
9,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
10,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
10,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
10,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
11,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
12,1,Biliary ischaemia,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
12,2,Cholangitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
12,3,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
13,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
13,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
13,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
13,4,Clostridium bacteraemia,Clostridia infections,Bacterial infectious disorders,Infec,N
13,5,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
13,6,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
13,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,8,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
13,9,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
13,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
14,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
14,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
15,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
16,1,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
16,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
17,1,Venous intravasation,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
18,1,Venous intravasation,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
19,1,Venous intravasation,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
20,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
20,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
21,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
21,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
21,3,Portal vein pressure increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
